Bipolar disorder and pregnancy: Maintaining psychiatric stability in the real world of obstetric and psychiatric complications

American Journal of Psychiatry

Volumn 167, Issue 8, 2010, Pages 892-897

  Burt, Vivien K ^a   Caryn, Bernstein ^a   Rosenstein, Wendy S ^a   Altshuler, Lori L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBAMAZEPINE; CITALOPRAM; CLOMIFENE; CLOMIPRAMINE; CLONAZEPAM; CLOZAPINE; ETHINYLESTRADIOL PLUS ETYNODIOL DIACETATE; FLUOXETINE; INSULIN; LAMOTRIGINE; LEVOTHYROXINE; LITHIUM; METFORMIN; MOOD STABILIZER; OLANZAPINE; PROGESTERONE; PSYCHOSTIMULANT AGENT; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN; RISPERIDONE; SERTRALINE; TEMAZEPAM; TIOTIXENE; TOPIRAMATE; UNINDEXED DRUG; VALPROIC ACID; VENLAFAXINE;

ADULT; AGITATION; AKATHISIA; AUTOMUTILATION; BIPOLAR DISORDER; BULIMIA; CASE REPORT; CESAREAN SECTION; CHRONIC DISEASE; CONFERENCE PAPER; CONTRACEPTION; DECISION MAKING; DEPRESSION; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROCONVULSIVE THERAPY; FEMALE; FETUS; HUMAN; HYPERSOMNIA; HYPOTHYROIDISM; MAJOR DEPRESSION; MANIA; MENTAL DISEASE; MENTAL PATIENT; MOTHER; OVARY POLYCYSTIC DISEASE; PATIENT COUNSELING; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PREMATURE LABOR; PRENATAL SCREENING; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; PUERPERIUM; RISK BENEFIT ANALYSIS; SIDE EFFECT; SOCIAL SUPPORT; SPONTANEOUS ABORTION; SUICIDE ATTEMPT; TREATMENT OUTCOME; TREATMENT PLANNING; TREMOR; WEIGHT GAIN;

ADULT; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CHILD DEVELOPMENT; CLOZAPINE; FEMALE; HUMANS; INFANT, NEWBORN; LITHIUM COMPOUNDS; OBSTETRIC LABOR COMPLICATIONS; OBSTETRICS; PHYSICIAN'S ROLE; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PRENATAL CARE; PSYCHIATRY;

EID: 77955366037     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2009.09081248     Document Type: Conference Paper

References (20)

1. Yonkers KA, Wisner KL, Stowe Z, Leibenluft E, Cohen L, Miller L, Manber R, Viguera A, Suppes T, Altshuler L: Management of bipolar disorder during pregnancy and the postpartum period. Am J Psychiatry 2004; 161:608-620 (Pubitemid 38445503)
2. Viguera AC , Cohen LS, Baldessarini RJ, Nonacs R: Managing bipolar disorder during pregnancy: weighing the risks and benefits. Can J Psychiatry 2002; 47:426-436
3. Wisner KL, Sit DK, Moses EL: Antipsychotic treatment during pregnancy: a model for decision-making. Adv Schizophrenia Clin Psychiatry 2007; 3:48-55
4. Newport DJ, Viguera AC , Beach AJ, Ritchie JC , Cohen LS, Stowe ZN: Lithium placental passage and obstetrical outcome: implications for clinical management during late pregnancy. Am J Psychiatry 2005; 162:2162-2170
5. Burt VK, Stein K: Treatment of women, in The American Psychiatric Publishing Textbook of Psychiatry, 5th ed. Edited by Hales RE, Yudofsky SC , Gabbard GO. Washington, DC , American Psychiatric Publishing, Inc, 2008, pp 1489-1525
6. Altshuler LL, Cohen L, Szuba MP, Burt VK, Gitlin M, Mintz J: Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines. Am J Psychiatry 1996; 153:592-606 (Pubitemid 26133611)
7. Krishnana KR: Psychiatric and medical comorbidities of bipolar disorder. Psychosom Med 2005; 67:1-8
8. Viguera AC , Newport DJ, Ritchie J, Stowe Z, W hitfield T, Mogielnicki J, Baldessarini RJ, Zurick A, Cohen LS: Lithium in breast milk and nursing infants: clinical implications. Am J Psychiatry 2007; 164:342-345
9. American Academy of Pediatrics Committee on Drugs: The transfer of drugs and other chemicals into human milk. Pediatrics 2001; 108:776-789
10. Burt VK, Suri R, Altshuler L, Stowe Z, Hendrick VC , Muntean E: The use of psychotropic medications during breast-feeding. Am J Psychiatry 2001; 158:1001-1009
11. Coppola D, Russo LJ, Kwarta RF, Varughese A, Schmider J: Evaluating the postmarketing experience of risperidone use during pregnancy: pregnancy and neonatal outcomes. Drug Saf 2007; 30:247-264 (Pubitemid 46425636)
12. McKenna K, Koren G, Tetelbaum M, Wilton L, Shakir S, Diav-Citrin O, Levinson A, Zipursky RB, Einarson A: Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study. J Clin Psychiatry 2005; 66:444-449 (Pubitemid 40593572)
13. Mendhekar DN, War L, Sharma JB, Jiloha RC: Olanzapine and pregnancy. Pharmacopsychiatry 2002; 35:122-123
14. Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL: Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 1996; 335:1010-1015 (Pubitemid 26338730)
15. Moses-Kolko E, Bogen D, Perel J, Bregar A, Uhl K, Levin B, Wisner KL: Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. JAMA 2005; 293:2372-2383 (Pubitemid 40676760)
16. Chambers CD, Hernandez-Diaz S, Van Marter LJ, Werler MM, Louik C , Jones KL, Mitchell AA: Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 2006; 354:579-587 (Pubitemid 43209105)
17. Alwan S, Reefhuis J, Rasmussen SA, Olney RS, Friedman JM: Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med 2007; 356:2684-2692 (Pubitemid 47001036)
18. Louik C , Lin AE, Werler MM, Hernandez-Diaz S, Mitchell AA: First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N Engl J Med 2007; 356:2675-2683 (Pubitemid 47001035)
19. Holmes LM, Wyszynski DF, Baldwin EJ, Habecker E, Glassman LH, Smith CR: Increased risk for nonsyndromal cleft palate among infants exposed to lamotrigine during pregnancy (abstract). Birth Defects Res A Clin M ol Teratol 2006; 76:318
20. Dolk H, Jenttink J, Loane M, Morris J, de Jong-van den Berg LTW: Does lamotrigine use in pregnancy increase orofacial cleft risk relative to other malformations? Neurology 2008; 71:714-722